Human Genome Epidemiology Literature Finder
|
Records 1 - 14 (of 14 Records) |
| Query Trace: DNA Damage and MTOR[original query] |
|---|
| Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets. Nature communications 2016 Oct 7 13131. Chen Ying-Bei, Xu Jianing, Skanderup Anders Jacobsen, Dong Yiyu, Brannon A Rose, Wang Lu, Won Helen H, Wang Patricia I, Nanjangud Gouri J, Jungbluth Achim A, Li Wei, Ojeda Virginia, Hakimi A Ari, Voss Martin H, Schultz Nikolaus, Motzer Robert J, Russo Paul, Cheng Emily H, Giancotti Filippo G, Lee William, Berger Michael F, Tickoo Satish K, Reuter Victor E, Hsieh James |
| A Randomized Phase II Neoadjuvant Study of Cisplatin, Paclitaxel With or Without Everolimus in Patients with Stage II/III Triple-Negative Breast Cancer (TNBC): Responses and Long-term Outcome Correlated with Increased Frequency of DNA Damage Response Gene Mutations, TNBC Subtype, AR Status, and Ki67. Clinical cancer research : an official journal of the American Association for Cancer Research 2017 Aug 23 (15): 4035-4045. Jovanovic Bojana, Mayer Ingrid A, Mayer Erica L, Abramson Vandana G, Bardia Aditya, Sanders Melinda E, Kuba M Gabriela, Estrada Monica V, Beeler J Scott, Shaver Timothy M, Johnson Kimberly C, Sanchez Violeta, Rosenbluth Jennifer M, Dillon Patrick M, Forero-Torres Andres, Chang Jenny C, Meszoely Ingrid M, Grau Ana M, Lehmann Brian D, Shyr Yu, Sheng Quanhu, Chen Sheau-Chiann, Arteaga Carlos L, Pietenpol Jennifer |
| Copy number variations of E2F1: a new genetic risk factor for testicular cancer. Endocrine-related cancer 2017 Jan . Rocca Maria Santa, Di Nisio Andrea, Marchiori Arianna, Ghezzi Marco, Opocher Giuseppe, Foresta Carlo, Ferlin Alber |
| MTOR Variation Related to Heat Resistance of Chinese Cattle. Animals : an open access journal from MDPI 2019 11 9 (11): . Ning Qingqing, Qu Kaixing, Hanif Quratulain, Jia Yutang, Cheng Haijian, Zhang Jicai, Chen Ningbo, Chen Hong, Huang Bizhi, Lei Chuzh |
| A Comprehensive Multiomics Analysis Identified Ubiquilin 4 as a Promising Prognostic Biomarker of Immune-Related Therapy in Pan-Cancer. Journal of oncology 2021 9 2021 7404927. Li Jie, Tong Ye, Wang Zhi, Liu Yi, Dai Xiaobo, Zhu Yu |
| Integrated Genomic Profiling and Drug Screening of Patient-Derived Cultures Identifies Individualized Copy Number-Dependent Susceptibilities Involving PI3K Pathway and 17q Genes in Neuroblastoma. Frontiers in oncology 2021 11 11 709525. Wong Rachel L Y, Wong Megan R E, Kuick Chik Hong, Saffari Seyed Ehsan, Wong Meng Kang, Tan Sheng Hui, Merchant Khurshid, Chang Kenneth T E, Thangavelu Matan, Periyasamy Giridharan, Chen Zhi Xiong, Iyer Prasad, Tan Enrica E K, Soh Shui Yen, Iyer N Gopalakrishna, Fan Qiao, Loh Amos H |
| Impact of AKT1 polymorphism on DNA damage, BTG2 expression, and risk of colorectal cancer development. Radiology and oncology 2022 Aug 56 (3): 336-345. Zubair Hina, Khan Zahid, Imran Muhamm |
| The Diverse Analysis Identifies Mutated KRAS Associated With Radioresistance in Non-Small Cell Lung Cancer. World journal of oncology 2022 5 13 (2): 84-95. Zhu Dao Qi, Liu Ying, Yu Zhi Jian, Zhang Ru Hua, Li Ai Wu, Gong Feng Ying, Wang Wei, Xiao Wei, Fan Q |
| Next-generation Sequencing Reveals Age-dependent Genetic Underpinnings in Lung adenocarcinoma. Journal of Cancer 2022 4 13 (5): 1565-1572. Wu Xiaonan, Zhao Jun, Yang Ling, Nie Xin, Wang Zheng, Zhang Ping, Li Chao, Hu Xueqing, Tang Min, Yi Yuting, Du Xinhua, Xia Xuefeng, Guan Yanfang, Yu Zicheng, Gu Wenguang, Quan Xiangming, Li Lin, Shi Ho |
| Genomic analyses of germline and somatic variation in high-grade serous ovarian cancer. Journal of ovarian research 2023 7 16 (1): 141. A W Adamson, Y C Ding, L Steele, L A Leong, R Morgan, M T Wakabayashi, E S Han, T H Dellinger, P S Lin, A A Hakim, S Wilczynski, C D Warden, S Tao, V Bedell, M C Cristea, S L Neuhaus |
| Molecular typing and mutational characterization of rectal neuroendocrine neoplasms. Cancer medicine 2023 6 . Xiaoling Duan, Man Zhao, Xiaolei Yin, Lili Mi, Jianfei Shi, Ning Li, Xin Han, Guangjie Han, Jinfeng Wang, Jiaojiao Hou, Fei Y |
| Co-mutations and KRAS G12C inhibitor efficacy in advanced NSCLC. Cancer discovery 2023 4 . Negrao Marcelo V, Araujo Haniel A, Lamberti Giuseppe, Cooper Alissa J, Akhave Neal S, Zhou Teng, Delasos Lukas, Hicks J Kevin, Aldea Mihaela, Minuti Gabriele, Hines Jacobi, Aredo Jacqueline V, Dennis Michael J, Chakrabarti Turja, Scott Susan C, Bironzo Paolo, Scheffler Matthias, Christopoulos Petros, Stenzinger Albrecht, Riess Jonathan W, Kim So Yeon, Goldberg Sarah B, Li Mingjia, Wang Qi, Qing Yun, Ni Ying, Do Minh Truong, Lee Richard, Ricciuti Biagio, Alessi Joao Victor, Wang Jing, Resuli Blerina, Landi Lorenza, Tseng Shu-Chi, Nishino Mizuki, Digumarthy Subba R, Rinsurongkawong Waree, Rinsurongkawong Vadeerat, Vaporciyan Ara A, Blumenschein George R, Zhang Jianjun, Owen Dwight H, Blakely Collin M, Mountzios Giannis, Shu Catherine A, Bestvina Christine M, Garassino Marina Chiara, Marrone Kristen A, Gray Jhanelle E, Patel Sandip Pravin, Cummings Amy L, Wakelee Heather A, Wolf Juergen, Scagliotti Giorgio Vittorio, Cappuzzo Federico, Barlesi Fabrice, Patil Pradnya D, Drusbosky Leylah, Gibbons Don L, Meric-Bernstam Funda, Lee J Jack, Heymach John V, Hong David S, Heist Rebecca S, Awad Mark M, Skoulidis Ferdinand |
| Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian Cancer. Research square 2023 3 . Adamson Aaron W, Ding Yuan Chun, Steele Linda, Leong Lucile A, Morgan Robert, Wakabayashi Mark T, Han Ernest S, Dellinger Thanh H, Lin Paul S, Hakim Amy A, Wilczynski Sharon, Warden Charles D, Tao Shu, Bedell Victoria, Cristea Mihaela C, Neuhausen Susan |
| Genomic Alterations of Signaling and DNA Damage Repair Pathways in Non-Muscle Invasive Bladder Cancer. Cancer investigation 2023 11 1-10. Serdar Celik, Tekincan Aktas, Ozde Gokbayrak, Aylin Erol, Kutsal Yorukoglu, Batuhan Yilmaz, Hilmi Sari, Zekiye Altun, Mehmet Ugur Mungan, Ilhan Celebi, Guven Aslan, Safiye Akt |
- Page last reviewed:Feb 1, 2024
- Content source: